CLINICAL_TRIALS
trial_result
· 2009-10-16
Clinical Trial Update: Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis [Phase 4]
Summary
Phase 4 clinical trial evaluating Aranesp (darbepoetin alfa) in subjects with end-stage renal disease on chronic hemodialysis has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: End Stage Renal Disease | Phase 4 | Status: COMPLETED